Novak Daniel, Hüser Laura, Elton Jonathan J, Umansky Viktor, Altevogt Peter, Utikal Jochen
Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
Semin Cancer Biol. 2020 Dec;67(Pt 1):74-82. doi: 10.1016/j.semcancer.2019.08.007. Epub 2019 Aug 11.
The transcription factor SOX2 is essential for embryonic development and plays a crucial role in maintaining the stemness of embryonic cells and various adult stem cell populations. On the other hand, dysregulation of SOX2 expression is associated with a multitude of cancer types and it has been shown that SOX2 positively affects cancer cell traits such as the capacity to proliferate, migrate, invade and metastasize. Moreover, there is growing evidence that SOX2 mediates resistance towards established cancer therapies and that it is expressed in cancer stem cells. These findings indicate that studying the role of SOX2 in the context of cancer progression could lead to the development of new therapeutic options. In this review, the current knowledge about the role of SOX2 in development, maintenance of stemness, cancer progression and the resistance towards cancer therapies is summarized.
转录因子SOX2对胚胎发育至关重要,在维持胚胎细胞及多种成体干细胞群的干性方面发挥着关键作用。另一方面,SOX2表达失调与多种癌症类型相关,并且已表明SOX2对癌细胞特性如增殖、迁移、侵袭和转移能力有正向影响。此外,越来越多的证据表明SOX2介导对既定癌症治疗的抗性,且其在癌症干细胞中表达。这些发现表明,研究SOX2在癌症进展中的作用可能会带来新的治疗选择。在这篇综述中,总结了关于SOX2在发育、干性维持、癌症进展及癌症治疗抗性方面作用的当前知识。